[go: up one dir, main page]

DE3876813D1 - 3(2h)pyridazinon, verfahren zu dessen herstellung und dieses enthaltendes mittel gegen srs-a. - Google Patents

3(2h)pyridazinon, verfahren zu dessen herstellung und dieses enthaltendes mittel gegen srs-a.

Info

Publication number
DE3876813D1
DE3876813D1 DE8888100798A DE3876813A DE3876813D1 DE 3876813 D1 DE3876813 D1 DE 3876813D1 DE 8888100798 A DE8888100798 A DE 8888100798A DE 3876813 A DE3876813 A DE 3876813A DE 3876813 D1 DE3876813 D1 DE 3876813D1
Authority
DE
Germany
Prior art keywords
hydrogen
alkyl
branched
straight chained
pyridazinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888100798A
Other languages
English (en)
Other versions
DE3876813T4 (de
DE3876813T2 (de
Inventor
Keizo Tanikawa
Ryozo Sakoda
Ken-Ichi Nissan Chemic Shikada
Tanaka Nissan Chemical Sakuya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissan Chemical Corp
Original Assignee
Nissan Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Corp filed Critical Nissan Chemical Corp
Application granted granted Critical
Publication of DE3876813D1 publication Critical patent/DE3876813D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22Nitrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE8888100798A 1987-01-20 1988-01-20 3(2h)pyridazinon, verfahren zu dessen herstellung und dieses enthaltendes mittel gegen srs-a. Expired - Fee Related DE3876813D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1023187 1987-01-20

Publications (1)

Publication Number Publication Date
DE3876813D1 true DE3876813D1 (de) 1993-02-04

Family

ID=11744513

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8888100798A Expired - Fee Related DE3876813D1 (de) 1987-01-20 1988-01-20 3(2h)pyridazinon, verfahren zu dessen herstellung und dieses enthaltendes mittel gegen srs-a.
DE3876813T Expired - Lifetime DE3876813T4 (de) 1987-01-20 1988-01-20 3(2H)Pyridazinon, Verfahren zu dessen Herstellung und dieses enthaltendes Mittel gegen SRS-A.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE3876813T Expired - Lifetime DE3876813T4 (de) 1987-01-20 1988-01-20 3(2H)Pyridazinon, Verfahren zu dessen Herstellung und dieses enthaltendes Mittel gegen SRS-A.

Country Status (10)

Country Link
US (1) US4978665A (de)
EP (1) EP0275997B1 (de)
AT (1) ATE83773T1 (de)
AU (1) AU597141B2 (de)
CA (1) CA1324792C (de)
DD (1) DD287497A5 (de)
DE (2) DE3876813D1 (de)
HU (1) HU198696B (de)
SU (1) SU1584750A3 (de)
ZA (1) ZA88309B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0641455B2 (ja) * 1984-12-10 1994-06-01 日産化学工業株式会社 ピリダジノン誘導体
IE62890B1 (en) * 1988-12-06 1995-03-08 Hafslund Nycomed Pharma New piperazinylalkyl-3(2h)-pyridazinones process for the preparation thereof and the use thereof as agents lowering blood pressure
JPH02256668A (ja) * 1988-12-20 1990-10-17 Nissan Chem Ind Ltd ピリダジノン誘導体
DE4009761A1 (de) * 1989-07-28 1991-01-31 Bayer Ag 2h-pyridazinon-derivate
DK0482208T3 (da) * 1990-04-25 2000-09-18 Nissan Chemical Ind Ltd Pyridazinonderivat
JPH0517357A (ja) * 1991-07-05 1993-01-26 Nissan Chem Ind Ltd 血小板減少療法剤
IL110040A (en) * 1993-06-29 2000-07-16 Nissan Chemical Ind Ltd Pyridazinone derivatives their preparation and pharmaceutical compositions comprising them
AU681694B2 (en) * 1993-09-06 1997-09-04 Ishihara Sangyo Kaisha Ltd. Pyridazinone derivatives or their salts, processes for theirproduction, and anti-shock agents containing them
TW326041B (en) * 1993-12-16 1998-02-01 Nippon Nouyaku Kk Pyridazinone derivatives, their production process and their use for inhibition of platelet aggregation
WO1995019969A1 (en) * 1994-01-25 1995-07-27 Nissan Chemical Industries, Ltd. Pyridazinone derivative
IL112695A (en) * 1994-02-22 1999-04-11 Green Cross Corp Pharmaceutical compositions containing pyridazinone derivatives
DE19516350A1 (de) * 1995-05-04 1996-11-07 Du Pont Deutschland Photothermographisches lichtempfindliches Aufzeichnungsmaterial mit vermindertem Schleier
CZ20012020A3 (cs) * 1998-12-07 2001-10-17 Nissan Chemical Industries, Ltd. Činidlo pro léčbu erektilní dysfunkce
US7132445B2 (en) 2001-04-16 2006-11-07 Schering Corporation 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
US20040106794A1 (en) 2001-04-16 2004-06-03 Schering Corporation 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
CN1599734A (zh) 2001-10-12 2005-03-23 先灵公司 作为cxc趋化因子受体拮抗剂的3,4-二取代的马来酰亚胺化合物
US6878709B2 (en) * 2002-01-04 2005-04-12 Schering Corporation 3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists
WO2003080053A1 (en) 2002-03-18 2003-10-02 Schering Corporation Combination treatments for chemokine-mediated diseases
EP1551818B1 (de) 2002-10-09 2009-02-04 Schering Corporation Thiadiazoldioxide und thiadiazoloxide als cxc- und cc-chemokinrezeptor liganden
DE602004016211D1 (en) 2003-12-19 2008-10-09 Schering Corp Thiadiazole als cxc- und cc-chemokinrezeptorliganden
WO2005068460A1 (en) 2003-12-22 2005-07-28 Schering Corporation Isothiazole dioxides as cxc- and cc- chemokine receptor ligands
US7718678B2 (en) 2005-06-29 2010-05-18 Schering Corporation Di-substituted oxadiazoles as CXC-chemokine receptor ligands
DE602006017849D1 (de) 2005-06-29 2010-12-09 Schering Corp 5,6-disubstituierte oxadiazolopyrazine und thiadiazolopyrazine als liganden des cxc-chemokinrezeptors
MY202046A (en) * 2018-09-27 2024-03-30 Fmc Corp Intermediates for Preparing Herbicidal Pyridazinones

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA784639A (en) * 1968-05-07 C. Olson Harold Herbicidal compositions
FR1441438A (fr) * 1963-11-13 1966-06-10 Basf Ag Procédé pour la préparation de nitro-4 amino-5 pyridazones-6
FR1413955A (fr) * 1964-06-03 1965-10-15 Basf Ag Procédé pour la préparation d'amino-4 halogéno-5 pyridazones-6
US4296120A (en) * 1980-08-28 1981-10-20 Pfizer Inc. (Carboxy-oxo-pyrrolidino)phenylalkenamides and esters thereof as SRS-A antagonists
JPH0641455B2 (ja) * 1984-12-10 1994-06-01 日産化学工業株式会社 ピリダジノン誘導体
JPH0641454B2 (ja) * 1985-02-27 1994-06-01 日産化学工業株式会社 ピリダジノン誘導体
US4892947A (en) * 1985-04-27 1990-01-09 Nissan Chemical Industries Ltd. 3(2H)Pyridazinone, process for its preparation and anti-allergic agent containing it

Also Published As

Publication number Publication date
ZA88309B (en) 1988-07-01
EP0275997A1 (de) 1988-07-27
ATE83773T1 (de) 1993-01-15
DD287497A5 (de) 1991-02-28
HUT46313A (en) 1988-10-28
US4978665A (en) 1990-12-18
AU597141B2 (en) 1990-05-24
EP0275997B1 (de) 1992-12-23
DE3876813T4 (de) 1995-05-11
DE3876813T2 (de) 1993-04-29
CA1324792C (en) 1993-11-30
SU1584750A3 (ru) 1990-08-07
HU198696B (en) 1989-11-28
AU1039688A (en) 1988-07-21

Similar Documents

Publication Publication Date Title
DE3876813D1 (de) 3(2h)pyridazinon, verfahren zu dessen herstellung und dieses enthaltendes mittel gegen srs-a.
JPS568361A (en) Pyroglutamic acid derivative and analogue
FI892787A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-indolyylialkyyli-4-(substituoitu pyridinyyli)piperatsiinien valmistamiseksi
TW368501B (en) 7-(2-aminoethyl)-benzothiazolones
FI893467A0 (fi) Menetelmä lääkeaineena käyttökelpoisten 4-oksokinoliini-3-karboksyylihapon johdannaisten valmistamiseksi
ATE57699T1 (de) Pyridoncarbonsauere-derivate und verfahren zu ihrer herstellung.
GB0018272D0 (en) Chemical compounds IV
CA2203237A1 (en) Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
ATE164582T1 (de) 1-methylcarbapenemderivate und verfahren zu ihrer herstellung
CO4980887A1 (es) Nueva 3,4-diariltiazolina-2-uno o 2-tiono derivados, sus metodos de preparacion y su uso terapeutico
ATE44748T1 (de) 4-substituierte 6-alkylidene-androsten-3,17-dion- derivate und verfahren zu ihrer herstellung.
ES2073258T3 (es) Nuevos derivados de la urea, su preparacion y su aplicacion en terapeutica.
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
ATE34394T1 (de) Therapeutisch aktive di-, tri-, tetra- und penta- aza-indene.
GR3030234T3 (en) 4-Phenylcarbamoyl-3-isoxazolecarboxylic acid derivatives with antiinflammatory activity
AU576887B2 (en) 1,6-naphthyridine derivatives
MY109714A (en) Process for preparing 8-chloroquinolone derivatives
ATE58135T1 (de) 1,3-oxathianderivate.
ES8103740A1 (es) Procedimiento para la obtencion de nuevos derivados de la piperacina metanimina
ES471895A1 (es) Procedimiento para preparar derivados de benzamidina
NZ504299A (en) 1-aza-2-alkyl-6-aryl-cycloalkane compounds, a process for their preparation and pharmaceutical compositions containing them
ATE52509T1 (de) Thiazolidinderivate und verfahren zu ihrer herstellung.
ATE139767T1 (de) Verfahren zur herstellung 5-pyrazolomerkaptan- derivate und dessen zwischenprodukte
ATE53839T1 (de) 2,3-dihydro-3-phenyl-benzofuran-2-onacetamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ES8307812A1 (es) Un procedimiento para la preparacion de nuevos amidin derivados del acido clavulawilo.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee